IC
MRK icon

Inscription Capital’s Merck MRK Stock Holding History

Inscription Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.93M Buy
24,350
+409
+2% +$47.2K 0.31% 56
2025
Q4 		$2.52M Sell
23,941
-539
-2% -$50.6K 0.26% 57
2025
Q3 		$2.05M Buy
24,480
+700
+3% +$57.7K 0.22% 68
2025
Q2 		$1.88M Sell
23,780
-13,867
-37% -$1.1M 0.27% 65
2025
Q1 		$4.97M Buy
+37,647
New +$3.51M 0.82% 24
2024
Q3 		$4.03M Sell
35,496
-1,646
-4% -$196K 0.6% 30
2024
Q2 		$4.6M Sell
37,142
-505
-1% -$65K 0.74% 25
2024
Q1 		$4.97M Buy
37,647
+6,808
+22% +$839K 0.82% 24
2023
Q4 		$3.36M Buy
30,839
+1,922
+7% +$200K 0.92% 21
2023
Q3 		$2.98M Sell
28,917
-50
-0.2% -$5.39K 0.97% 20
2023
Q2 		$3.34M Sell
28,967
-768
-3% -$87.2K 1.04% 21
2023
Q1 		$3.16M Buy
29,735
+103
+0.3% +$11.1K 0.84% 24
2022
Q4 		$3.29M Sell
29,632
-205
-0.7% -$21K 1.12% 17
2022
Q3 		$2.57M Sell
29,837
-137,405
-82% -$12.3M 0.73% 25
2022
Q2 		$15.2M Buy
167,242
+136,760
+449% +$12.1M 2.75% 6
2022
Q1 		$2.52M Sell
30,482
-1,700
-5% -$134K 0.72% 34
2021
Q4 		$2.49M Buy
32,182
+2,601
+9% +$207K 0.68% 37
2021
Q3 		$2.24M Sell
29,581
-53,170
-64% -$4.04M 0.7% 39
2021
Q2 		$6.44M Buy
82,751
+52,690
+175% +$3.92M 0.73% 26
2021
Q1 		$2.23M Sell
30,061
-3,150
-9% -$232K 0.76% 38
2020
Q4 		$2.61M Buy
33,211
+2,087
+7% +$160K 1.01% 25
2020
Q3 		$2.48M Sell
31,124
-499
-2% -$39.1K 1.1% 20
2020
Q2 		$2.35M Buy
31,623
+3,521
+13% +$265K 1.3% 16
2020
Q1 		$2.08M Sell
28,102
-471
-2% -$37K 1.38% 17
2019
Q4 		$2.5M Buy
28,573
+7,576
+36% +$622K 1.11% 19
2019
Q3 		$1.7M Buy
+20,997
New +$1.68M 0.93% 25
2019
Q2 		– Sell
-892
Closed -$71K – 195
2019
Q1 		$71K Sell
892
-540
-38% -$40.4K 0.04% 178
2018
Q4 		$105K Buy
+1,432
New +$101K 0.06% 158

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Inscription Capital's MRK Position: Q1 2026 in Review

Inscription Capital increased its Merck (MRK) stake by 1.7% in Q1 2026, buying an estimated $47.2K and bringing the position to 24,350 shares worth $2.93M. The position accounts for 0.31% of the portfolio, ranked #56.

Inscription Capital first reported a position in MRK in Q4 2018 and has held it in 28 quarters since. The position peaked at $15.2M in Q2 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Inscription Capital held 24,350 shares of Merck worth $2.93M as of Q1 2026.
  • Inscription Capital bought 409 Merck shares in Q1 2026, an estimated $47.2K.
  • Merck made up 0.31% of Inscription Capital's portfolio in Q1 2026, its #56 holding.
  • Inscription Capital first reported a position in Merck in Q4 2018 and has held it in 28 quarters since.
  • Inscription Capital's Merck position peaked at $15.2M in Q2 2022.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.